CHRYSTAL PRATT: Open Payments
NPI 1437919925 · LATROBE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,702 in 184 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $551 · 2025 $2,702
Food & beverage: $2,702
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 80 | $1,015 |
| Vanda Pharmaceuticals Inc. | 17 | $291 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $282 |
| Otsuka America Pharmaceutical, Inc. | 17 | $253 |
| Neurocrine BioSciences, Inc. | 15 | $216 |
| Teva Pharmaceuticals USA, Inc. | 10 | $175 |
| Supernus Pharmaceuticals, Inc. | 9 | $115 |
| Janssen Pharmaceuticals, Inc | 5 | $92 |
| Lundbeck LLC | 5 | $85 |
| Alkermes, Inc. | 4 | $75 |
Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, HETLIOZ, FANAPT, AUSTEDO XR, Qelbree.
Industry payments across PA — which companies pay providers there.
